About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Micro-environment Involvement in Muscle Alteration Induced

NCT04448626·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University Hospital, Montpellier

With

APARD Fonds de dotation

Age

40–85

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Hospitalization for COPD exacerbation 2/ for COPD patients
COPD patients GOLD II à IV
Not having followed respiratory réhabilitation stay for at least one year 3/ for Healthy subjects
healthy and sedentary (Voorips score \<9)

You may not be if

1. for COPD patients hospitalized for exacerbation:
* concomitant acute cardiac évent
* trachéal intubation with mechanical ventilation
* chronic respiratory disease other than COPD
* locomotor, neurologic or psychiatric comorbidities
2. for COPD patients
* Exacerbation with récent hospitalization (\<4 weeks)
* Neurologic comorbidity
3. for Healthy subjects - long term drug treatment with proven central effects

The record

StatusCompleted

PhaseNo phase

Taking part27

StartedMar 2020

UpdatedJun 26, 2020

Conditions

Chronic Obstructive Pulmonary Disease Exacerbations Skeletal Muscle Atrophy

Where1

Uhmontpellier
Montpellier, France

Clareo Health | Micro-environment Involvement in Muscle Alteration Induced